Protease activity sensors enable real-time treatment response monitoring in lymphangioleiomyomatosis

<jats:sec><jats:title>Background</jats:title><jats:p>Biomarkers of disease progression and treatment response are urgently needed for patients with lymphangioleiomyomatosis (LAM). Activity-based nanosensors, an emerging biosensor class, detect dysregulated proteases <jats:...

ver descrição completa

Detalhes bibliográficos
Principais autores: Kirkpatrick, Jesse D, Soleimany, Ava P, Dudani, Jaideep S, Liu, Heng-Jia, Lam, Hilaire C, Priolo, Carmen, Henske, Elizabeth P, Bhatia, Sangeeta N
Outros Autores: Koch Institute for Integrative Cancer Research at MIT
Formato: Artigo
Idioma:English
Publicado em: European Respiratory Society (ERS) 2022
Acesso em linha:https://hdl.handle.net/1721.1/142802